HUWE1 and cancer: Indeed, HectH9 knockdown sensitized cancer cell response to doxorubicin and paclitaxel in various cancer cells (Fig. 6j, k and Supplementary Fig. 5j, k), highlighting that targeting HectH9/HK2 axis could be a new approach for restoring cancer cells’ susceptibility to currently used chemotherapy.